Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 144 articles:
HTML format
Text format



Single Articles


    October 2019
  1. WU MJ, Shanmugam S, Welsch C, Yi M, et al
    Palmitoylation of the hepatitis C virus NS2 regulates its subcellular localization and NS2-NS3 autocleavage.
    J Virol. 2019 Oct 9. pii: JVI.00906-19. doi: 10.1128/JVI.00906.
    PubMed     Text format     Abstract available


    September 2019
  2. VAZQUEZ C, Tan CY, Horner SM
    Hepatitis C virus infection is inhibited by a non-canonical antiviral signaling pathway targeted by NS3-NS4A.
    J Virol. 2019 Sep 18. pii: JVI.00725-19. doi: 10.1128/JVI.00725.
    PubMed     Text format     Abstract available


  3. TSAI CN, Pan TC, Chiang CH, Yu CC, et al
    Serine 229 balances the hepatitis C virus nonstructural protein NS5A between hypo- and hyper-phosphorylated states.
    J Virol. 2019 Sep 11. pii: JVI.01028-19. doi: 10.1128/JVI.01028.
    PubMed     Text format     Abstract available


  4. WANG H, Tai AW
    Nir2 is an effector of VAPs necessary for efficient HCV replication and PI(4)P enrichment at the viral replication organelle.
    J Virol. 2019 Sep 4. pii: JVI.00742-19. doi: 10.1128/JVI.00742.
    PubMed     Text format     Abstract available


    August 2019
  5. JOHNSON J, Freedman H, Logan M, Wong JAJ, et al
    A recombinant HCV genotype 1a E1/E2 envelope glycoprotein vaccine elicits antibodies that differentially neutralize closely related 2a strains through interactions of the N-terminal hypervariable region 1 of E2 with scavenger receptor B1.
    J Virol. 2019 Aug 28. pii: JVI.00810-19. doi: 10.1128/JVI.00810.
    PubMed     Text format     Abstract available


  6. CHEN TI, Hsu YK, Chou CY, Chen YH, et al
    Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Non-Homologous End Joining.
    J Virol. 2019 Aug 28. pii: JVI.01273-19. doi: 10.1128/JVI.01273.
    PubMed     Text format     Abstract available


  7. SHWETHA S, Kumar A, Mullick R, Vasudevan D, et al
    Correction for Shwetha et al., "HuR Displaces Polypyrimidine Tract Binding Protein To Facilitate La Binding to the 3' Untranslated Region and Enhances Hepatitis C Virus Replication".
    J Virol. 2019;93.
    PubMed     Text format    


  8. HU J, Protzer U, Siddiqui A
    Revisiting Hepatitis B virus: Challenges of Curative Therapies.
    J Virol. 2019 Aug 2. pii: JVI.01032-19. doi: 10.1128/JVI.01032.
    PubMed     Text format     Abstract available


    July 2019
  9. SZKOLNICKA D, Pollan A, Da Silva N, Oechslin N, et al
    Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein.
    J Virol. 2019 Jul 17. pii: JVI.00459-19. doi: 10.1128/JVI.00459.
    PubMed     Text format     Abstract available


  10. SCHULT P, Nattermann M, Lauber C, Seitz S, et al
    Evidence for internal initiation of RNA synthesis by the Hepatitis C virus RNA-dependent RNA polymerase NS5B in cellulo.
    J Virol. 2019 Jul 17. pii: JVI.00525-19. doi: 10.1128/JVI.00525.
    PubMed     Text format     Abstract available


  11. MEKONNEN ZA, Grubor-Bauk B, English K, Leung P, et al
    Single dose vaccination with a hepatotropic Adeno-associated virus (AAV) efficiently localises T cell immunity in the liver with the potential to confer rapid protection against hepatitis C virus (HCV).
    J Virol. 2019 Jul 10. pii: JVI.00202-19. doi: 10.1128/JVI.00202.
    PubMed     Text format     Abstract available


  12. WOLFISBERG R, Holmbeck K, Nielsen L, Kapoor A, et al
    Replicons of a rodent hepatitis C model virus permit selection of highly permissive cells.
    J Virol. 2019 Jul 10. pii: JVI.00733-19. doi: 10.1128/JVI.00733.
    PubMed     Text format     Abstract available


    June 2019
  13. PATRA T, Sasaki R, Meyer K, Ray RB, et al
    TGF-beta acts as a regulatory molecule for lipogenic pathway among hepatitis C virus genotype specific infection.
    J Virol. 2019 Jun 26. pii: JVI.00811-19. doi: 10.1128/JVI.00811.
    PubMed     Text format     Abstract available


  14. KORNYEYEV D, Ramakrishnan D, Voitenleitner C, Livingston CM, et al
    Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes.
    J Virol. 2019 Jun 5. pii: JVI.00248-19. doi: 10.1128/JVI.00248.
    PubMed     Text format     Abstract available


  15. RAMAKRISHNAN D, Xing W, Beran RK, Chemuru S, et al
    Hepatitis B Virus X Protein Function Requires Zinc Binding.
    J Virol. 2019 Jun 5. pii: JVI.00250-19. doi: 10.1128/JVI.00250.
    PubMed     Text format     Abstract available


  16. COSTAFREDA MI, Kaplan G
    Reply to Das et al., "TIM1 (HAVCR1): an Essential 'Receptor' or an 'Accessory Attachment Factor' for Hepatitis A Virus?"
    J Virol. 2019;93.
    PubMed     Text format    


  17. DAS A, Maury W, Lemon SM
    TIM1 (HAVCR1): an Essential "Receptor" or an "Accessory Attachment Factor" for Hepatitis A Virus?
    J Virol. 2019;93.
    PubMed     Text format    


    May 2019
  18. INOUE J, Ninomiya M, Umetsu T, Nakamura T, et al
    siRNA Screening for the Small GTPase Rab Proteins Identifies that Rab5B is a Major Regulator of Hepatitis B Virus Production.
    J Virol. 2019 May 22. pii: JVI.00621-19. doi: 10.1128/JVI.00621.
    PubMed     Text format     Abstract available


  19. COLBERT MD, Flyak AI, Ogega CO, Kinchen VJ, et al
    Broadly neutralizing antibodies targeting new sites of vulnerability in hepatitis C virus E1E2.
    J Virol. 2019 May 8. pii: JVI.02070-18. doi: 10.1128/JVI.02070.
    PubMed     Text format     Abstract available


  20. QIN Y, Xun Z, Guo Y, Chen S, et al
    Sam68 Promotes Hepatitis C Virus Replication by Interaction with Stem-Loop 2 of Viral 5' Untranslated Region.
    J Virol. 2019 May 8. pii: JVI.00693-19. doi: 10.1128/JVI.00693.
    PubMed     Text format     Abstract available


  21. ZHAO Z, Wang JC, Gonzalez-Gutierrez G, Venkatakrishnan B, et al
    Structural differences between the Woodchuck hepatitis virus core protein in dimer and capsid states are consistent with entropic and conformational regulation of assembly.
    J Virol. 2019 May 1. pii: JVI.00141-19. doi: 10.1128/JVI.00141.
    PubMed     Text format     Abstract available


    April 2019
  22. MITRA B, Wang J, Kim ES, Mao R, et al
    Hepatitis B Virus Precore Protein p22 Inhibits Interferon-alpha Signaling by Blocking STAT Nuclear Translocation.
    J Virol. 2019 Apr 24. pii: JVI.00196-19. doi: 10.1128/JVI.00196.
    PubMed     Text format     Abstract available


  23. PROUDFOOT A, Hyrina A, Holdorf M, Frank AO, et al
    First Crystal Structure of a Non-Structural Hepatitis E Viral Protein Identifies a Putative Novel Zinc-Binding Protein.
    J Virol. 2019 Apr 24. pii: JVI.00170-19. doi: 10.1128/JVI.00170.
    PubMed     Text format     Abstract available


    March 2019
  24. LI H, Fan M, Liu B, Ji P, et al
    Chicken organic anion transporting polypeptide 1A2, a novel avian hepatitis E virus (HEV) ORF2-interacting protein, is involved in avian HEV infection.
    J Virol. 2019 Mar 20. pii: JVI.02205-18. doi: 10.1128/JVI.02205.
    PubMed     Text format     Abstract available


  25. SHERAZ M, Cheng J, Tang L, Chang J, et al
    Cellular DNA topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA.
    J Virol. 2019 Mar 13. pii: JVI.02230-18. doi: 10.1128/JVI.02230.
    PubMed     Text format     Abstract available


  26. SAHUC ME, Sahli R, Riviere C, Pene V, et al
    Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus Is a New Inhibitor of Hepatitis C Virus RNA Replication.
    J Virol. 2019 Mar 6. pii: JVI.02009-18. doi: 10.1128/JVI.02009.
    PubMed     Text format     Abstract available


    February 2019
  27. FLECKEN T, Meier MA, Skewes-Cox P, Barkan DT, et al
    Mapping the heterogeneity of histone modifications on hepatitis B virus-DNA using liver needle biopsies obtained from chronically infected patients.
    J Virol. 2019 Feb 20. pii: JVI.02036-18. doi: 10.1128/JVI.02036.
    PubMed     Text format     Abstract available


  28. BANG BR, Li M, Tsai KN, Aoyagi H, et al
    Regulation of HCV infection by Cellular Retinoic Acid Binding Proteins through the modulation of lipid droplet abundance.
    J Virol. 2019 Feb 6. pii: JVI.02302-18. doi: 10.1128/JVI.02302.
    PubMed     Text format     Abstract available


  29. HARICHANDRAN K, Shen Y, Tsoris SS, Lee SC, et al
    Hepatitis Delta Antigen Regulates mRNA and Antigenome RNA Levels during Hepatitis Delta Virus Replication.
    J Virol. 2019 Feb 6. pii: JVI.01989-18. doi: 10.1128/JVI.01989.
    PubMed     Text format     Abstract available


    January 2019
  30. WANG L, Teng JL, Lau SKP, Sridhar S, et al
    Transmission of A Novel Genotype Hepatitis E Virus from Bactrian Camels to Cynomolgus Macaques.
    J Virol. 2019 Jan 30. pii: JVI.02014-18. doi: 10.1128/JVI.02014.
    PubMed     Text format     Abstract available


  31. YANG Q, Zhang Q, Zhang X, You L, et al
    HoxA10 Facilitates SHP-1-catalized Dephosphorylation of p38 MAPK/STAT3 to Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.
    J Virol. 2019 Jan 23. pii: JVI.01607-18. doi: 10.1128/JVI.01607.
    PubMed     Text format     Abstract available


  32. MARIN MQ, Perez P, Ljungberg K, Sorzano COS, et al
    Potent Anti-Hepatitis C (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-launched RNA Replicons and MVA-HCV.
    J Virol. 2019 Jan 23. pii: JVI.00055-19. doi: 10.1128/JVI.00055.
    PubMed     Text format     Abstract available


  33. URBANOWICZ RA, Wang R, Schiel JE, Keck ZY, et al
    Antigenicity and Immunogenicity of Differentially Glycosylated HCV E2 Envelope Proteins Expressed in Mammalian and Insect Cells.
    J Virol. 2019 Jan 16. pii: JVI.01403-18. doi: 10.1128/JVI.01403.
    PubMed     Text format     Abstract available


  34. KUSAKABE S, Suzuki T, Sugiyama Y, Haga S, et al
    USP15 participates in HCV propagation through the regulation of viral RNA translation and lipid droplet formation.
    J Virol. 2019 Jan 9. pii: JVI.01708-18. doi: 10.1128/JVI.01708.
    PubMed     Text format     Abstract available


    December 2018
  35. LEBSIR N, Goueslain L, Farhat R, Callens N, et al
    Functional and physical interaction between the Arf activator GBF1 and hepatitis C virus NS3 protein.
    J Virol. 2018 Dec 19. pii: JVI.01459-18. doi: 10.1128/JVI.01459.
    PubMed     Text format     Abstract available


  36. MOSHKANI S, Chiale C, Lang SM, Rose JK, et al
    A highly attenuated vesicular stomatitis virus-based vaccine platform controls HBV replication in mouse models of hepatitis B.
    J Virol. 2018 Dec 12. pii: JVI.01586-18. doi: 10.1128/JVI.01586.
    PubMed     Text format     Abstract available


  37. JACQUET S, Pons JB, De Bernardo A, Ngoubangoye B, et al
    Evolution of Hepatitis B Virus Receptor NTCP Reveals Differential Pathogenicity and Species-Specificities of Hepadnaviruses in Primates, Rodents and Bats.
    J Virol. 2018 Dec 12. pii: JVI.01738-18. doi: 10.1128/JVI.01738.
    PubMed     Text format     Abstract available


    November 2018
  38. VELAZQUEZ-MOCTEZUMA R, Galli A, Law M, Bukh J, et al
    Hepatitis C virus escape studies for human antibody AR3A reveals a high barrier to resistance and novel insights on viral antibody evasion mechanisms.
    J Virol. 2018 Nov 28. pii: JVI.01909-18. doi: 10.1128/JVI.01909.
    PubMed     Text format     Abstract available


  39. CAPELLI N, Marion O, Dubois M, Allart S, et al
    Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.
    J Virol. 2018 Nov 21. pii: JVI.01207-18. doi: 10.1128/JVI.01207.
    PubMed     Text format     Abstract available


  40. WANG Y, Cui L, Yang G, Zhan J, et al
    Hepatitis B e antigen inhibits NF-kappaB activity by interrupting K63-linked ubiquitination of NEMO.
    J Virol. 2018 Nov 7. pii: JVI.00667-18. doi: 10.1128/JVI.00667.
    PubMed     Text format     Abstract available


  41. MURATA Y, Kawashima K, Sheikh K, Tanaka Y, et al
    Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8(+) T Cell Responses.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    October 2018
  42. PHAM HT, Nguyen TTT, Nguyen LP, Han SS, et al
    Hepatitis C virus downregulates ubiquitin conjugating enzyme E2S expression to prevent proteasomal degradation of NS5A, leading to host cells more sensitive to DNA damage.
    J Virol. 2018 Oct 31. pii: JVI.01240-18. doi: 10.1128/JVI.01240.
    PubMed     Text format     Abstract available


  43. YI DR, An N, Liu ZL, Xu FW, et al
    Human MxB inhibits the replication of HCV.
    J Virol. 2018 Oct 17. pii: JVI.01285-18. doi: 10.1128/JVI.01285.
    PubMed     Text format     Abstract available


  44. BAI L, Zhang X, Li W, Wu M, et al
    Extracellular HBV RNAs are heterogeneous in length and circulate as capsid-antibody-complexes in addition to virions in chronic hepatitis B patients.
    J Virol. 2018 Oct 3. pii: JVI.00798-18. doi: 10.1128/JVI.00798.
    PubMed     Text format     Abstract available


    September 2018
  45. SCHENK C, Meyrath M, Warnken U, Schnolzer M, et al
    Characterization of a threonine-rich cluster in Hepatitis C virus nonstructural protein 5A and its contribution to hyperphosphorylation.
    J Virol. 2018 Sep 26. pii: JVI.00737-18. doi: 10.1128/JVI.00737.
    PubMed     Text format     Abstract available


  46. DOMINGUEZ-MOLINA B, Machmach K, Perales C, Tarancon-Diez L, et al
    Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells.
    J Virol. 2018 Sep 19. pii: JVI.01219-18. doi: 10.1128/JVI.01219.
    PubMed     Text format     Abstract available


  47. QIAO L, Sui J, Luo G
    Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication.
    J Virol. 2018 Sep 19. pii: JVI.01255-18. doi: 10.1128/JVI.01255.
    PubMed     Text format     Abstract available


  48. QU B, Ni Y, Lempp FA, Vondran FWR, et al
    T5 exonuclease hydrolysis of Hepatitis B Virus replicative intermediates allows reliable quantification and fast drug efficacy testing of covalently closed circular DNA by PCR.
    J Virol. 2018 Sep 19. pii: JVI.01117-18. doi: 10.1128/JVI.01117.
    PubMed     Text format     Abstract available


  49. GONZALEZ-LOPEZ O, Rivera-Serrano EE, Hu F, Hensley L, et al
    Redundant late domain functions of tandem VP2 YPX3L motifs in nonlytic cellular egress of quasi-enveloped hepatitis A virus.
    J Virol. 2018 Sep 19. pii: JVI.01308-18. doi: 10.1128/JVI.01308.
    PubMed     Text format     Abstract available


  50. WU SX, Chen WN, Jing ZT, Liu W, et al
    Hepatitis B spliced protein (HBSP) suppresses Fas-mediated hepatocyte apoptosis via activation of PI3K/Akt signaling.
    J Virol. 2018 Sep 12. pii: JVI.01273-18. doi: 10.1128/JVI.01273.
    PubMed     Text format     Abstract available


  51. KAWASHIMA K, Isogawa M, Hamada-Tsutsumi S, Baudi I, et al
    Type I interferon signaling prevents hepatitis B virus-specific T cell responses by reducing antigen expression.
    J Virol. 2018 Sep 12. pii: JVI.01099-18. doi: 10.1128/JVI.01099.
    PubMed     Text format     Abstract available


  52. BOEIJEN LL, Hou J, de Groen RA, Verbon A, et al
    Persistent replication of HIV, HCV and HBV results in distinct gene expression profiles by human NK cells.
    J Virol. 2018 Sep 5. pii: JVI.00575-18. doi: 10.1128/JVI.00575.
    PubMed     Text format     Abstract available


  53. XIE Q, Chen S, Tian R, Huang X, et al
    Long Noncoding RNA ITPRIP-1 Positively Regulates the Innate Immune Response through Promotion of Oligomerization and Activation of MDA5.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    August 2018
  54. PIRACHA ZZ, Kwon HJ, Saeed U, Kim J, et al
    Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis via the AKT/GSK-3beta/beta-Catenin Signaling Pathway.
    J Virol. 2018 Aug 15. pii: JVI.00955-18. doi: 10.1128/JVI.00955.
    PubMed     Text format     Abstract available


  55. YUGO DM, Heffron CL, Ryu J, Uh K, et al
    Infection dynamics of hepatitis E virus in wild-type and immunoglobulin heavy chain knockout JH (-/-) gnotobiotic piglets.
    J Virol. 2018 Aug 15. pii: JVI.01208-18. doi: 10.1128/JVI.01208.
    PubMed     Text format     Abstract available


  56. ZHAO Y, Cao X, Guo M, Wang X, et al
    NEURL3 is an inducible antiviral effector to inhibit HCV assembly by targeting viral E1 glycoprotein.
    J Virol. 2018 Aug 15. pii: JVI.01123-18. doi: 10.1128/JVI.01123.
    PubMed     Text format     Abstract available


  57. SUR S, Sasaki R, Devhare P, Steele R, et al
    Association between microRNA-373 and long non-coding RNA NORAD in hepatitis C virus infected hepatocytes impairs Wee1 expression for growth promotion.
    J Virol. 2018 Aug 8. pii: JVI.01215-18. doi: 10.1128/JVI.01215.
    PubMed     Text format     Abstract available


  58. HSU SC, Tsai CN, Lee KY, Pan TC, et al
    Sequential S232/S235/S238 Phosphorylation of the Hepatitis C Virus Nonstructural Protein 5A.
    J Virol. 2018 Aug 8. pii: JVI.01295-18. doi: 10.1128/JVI.01295.
    PubMed     Text format     Abstract available


  59. RUAN L, Hadden JA, Zlotnick A
    Assembly properties of Hepatitis B Virus core protein mutants correlate with their resistance to assembly-directed antivirals.
    J Virol. 2018 Aug 8. pii: JVI.01082-18. doi: 10.1128/JVI.01082.
    PubMed     Text format     Abstract available


  60. ANANG S, Kaushik N, Hingane S, Kumari A, et al
    Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101.
    J Virol. 2018 Aug 1. pii: JVI.00684-18. doi: 10.1128/JVI.00684.
    PubMed     Text format     Abstract available


  61. MOUSTAFA RI, Haddad JG, Linna L, Hanoulle X, et al
    Functional study of the C-terminal part of hepatitis C virus E1 ectodomain.
    J Virol. 2018 Aug 1. pii: JVI.00939-18. doi: 10.1128/JVI.00939.
    PubMed     Text format     Abstract available


    July 2018
  62. NYSTROM K, Wanrooij PH, Waldenstrom J, Adamek L, et al
    INOSINE TRIPHOSPHATE PYROPHOSPHATASE DEPHOSPHORYLATES RIBAVIRIN TRIPHOSPHATE AND REDUCED ENZYMATIC ACTIVITY POTENTIATES MUTAGENESIS IN HEPATITIS C VIRUS.
    J Virol. 2018 Jul 25. pii: JVI.01087-18. doi: 10.1128/JVI.01087.
    PubMed     Text format     Abstract available


  63. XIA Y, Cheng X, Li Y, Valdez K, et al
    Hepatitis B virus deregulates cell cycle to promote viral replication and a premalignant phenotype.
    J Virol. 2018 Jul 18. pii: JVI.00722-18. doi: 10.1128/JVI.00722.
    PubMed     Text format     Abstract available


    June 2018
  64. ZHANG Y, Wu Y, Deng M, Xu D, et al
    CD8(+) T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress.
    J Virol. 2018 Jun 27. pii: JVI.02120-17. doi: 10.1128/JVI.02120.
    PubMed     Text format     Abstract available


  65. LEE AR, Lim KH, Park ES, Kim DH, et al
    Multiple functions of c-FLIP are essential for replication of hepatitis B virus.
    J Virol. 2018 Jun 6. pii: JVI.00339-18. doi: 10.1128/JVI.00339.
    PubMed     Text format     Abstract available


  66. LI P, Shan Y, Zheng W, Ou X, et al
    Identification of H209 as Essential for pH 8-Triggered Receptor-Independent Syncytium Formation by S Protein of Mouse Hepatitis Virus A59.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    May 2018
  67. ABDUL F, Filleton F, Gerossier L, Paturel A, et al
    Smc5/6 Antagonism by HBx Is an Evolutionarily Conserved Function of Hepatitis B Virus Infection in Mammals.
    J Virol. 2018 May 30. pii: JVI.00769-18. doi: 10.1128/JVI.00769.
    PubMed     Text format     Abstract available


  68. LEE J, Zong L, Krotow A, Qin Y, et al
    N-linked glycosylation is not essential for sodium taurocholate cotransporting polypeptide to mediate hepatitis B virus infection in vitro.
    J Virol. 2018 May 23. pii: JVI.00732-18. doi: 10.1128/JVI.00732.
    PubMed     Text format     Abstract available


  69. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Correction for Belouzard et al., "Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes".
    J Virol. 2018;92.
    PubMed     Text format    


  70. FREITAS N, Lukash T, Gunewardena S, Chappell B, et al
    Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  71. NAIR S, Zlotnick A
    Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  72. NING X, Luckenbaugh L, Liu K, Bruss V, et al
    Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-free Hepatitis B Virions.
    J Virol. 2018 May 9. pii: JVI.00272-18. doi: 10.1128/JVI.00272.
    PubMed     Text format     Abstract available


    April 2018
  73. KIM JY, Ou JJ
    Regulation of Apolipoprotein E Trafficking by Hepatitis C Virus-induced Autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00211-18. doi: 10.1128/JVI.00211.
    PubMed     Text format     Abstract available


  74. DE OLIVEIRA CARNEIRO I, Sander AL, Silva N, Moreira-Soto A, et al
    A novel marsupial hepatitis A virus corroborates complex evolutionary patterns shaping the genus Hepatovirus.
    J Virol. 2018 Apr 25. pii: JVI.00082-18. doi: 10.1128/JVI.00082.
    PubMed     Text format     Abstract available


  75. MATSUI C, Deng L, Minami N, Abe T, et al
    Hepatitis C virus NS5A protein promotes the lysosomal degradation of hepatocyte nuclear factor 1alpha via chaperone-mediated autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00639-18. doi: 10.1128/JVI.00639.
    PubMed     Text format     Abstract available


  76. KARIMZADEH H, Kiraithe MM, Kosinska AD, Glaser M, et al
    Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells.
    J Virol. 2018 Apr 18. pii: JVI.01891-17. doi: 10.1128/JVI.01891.
    PubMed     Text format     Abstract available


  77. CHEN Y, Liu B, Sun Y, Li H, et al
    Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
    J Virol. 2018 Apr 18. pii: JVI.00251-18. doi: 10.1128/JVI.00251.
    PubMed     Text format     Abstract available


  78. ZHAO Q, Hu Z, Cheng J, Wu S, et al
    Hepatitis B virus core protein dephosphorylation occurs during pregenomic RNA encapsidation.
    J Virol. 2018 Apr 18. pii: JVI.02139-17. doi: 10.1128/JVI.02139.
    PubMed     Text format     Abstract available


  79. IQBAL J, Sarkar-Dutta M, McRae S, Ramachandran A, et al
    Osteopontin regulates HCV replication and assembly via interaction with HCV proteins and lipid droplets and by binding to receptors, alphaVbeta3 and CD44.
    J Virol. 2018 Apr 18. pii: JVI.02116-17. doi: 10.1128/JVI.02116.
    PubMed     Text format     Abstract available


    March 2018
  80. AUNINS TR, Marsh KA, Subramanya G, Uprichard SL, et al
    Intracellular hepatitis C modeling predicts infection dynamics and viral protein mechanisms.
    J Virol. 2018 Mar 21. pii: JVI.02098-17. doi: 10.1128/JVI.02098.
    PubMed     Text format     Abstract available


  81. NGUYEN TT, Park EM, Lim YS, Hwang SB, et al
    Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis.
    J Virol. 2018 Mar 21. pii: JVI.00178-18. doi: 10.1128/JVI.00178.
    PubMed     Text format     Abstract available


  82. NISHITSUJI H, Ujino S, Harada K, Shimotohno K, et al
    TIP60 Complex Inhibits Hepatitis B Virus Transcription.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  83. HALDIPUR B, Bhukya PL, Arankalle V, Lole K, et al
    Positive regulation of hepatitis E virus replication by microRNA-122.
    J Virol. 2018 Mar 14. pii: JVI.01999-17. doi: 10.1128/JVI.01999.
    PubMed     Text format     Abstract available


  84. LAW JLM, Logan M, Wong J, Kundu J, et al
    Role of the E2 hypervariable region (HVR1) in the immunogenicity of a recombinant HCV vaccine.
    J Virol. 2018 Mar 14. pii: JVI.02141-17. doi: 10.1128/JVI.02141.
    PubMed     Text format     Abstract available


  85. SUFFNER S, Gerstenberg N, Patra M, Ruibal P, et al
    Domains of the hepatitis B virus small surface protein S mediating oligomerization.
    J Virol. 2018 Mar 14. pii: JVI.02232-17. doi: 10.1128/JVI.02232.
    PubMed     Text format     Abstract available


    February 2018
  86. RIVA L, Song OR, Prentoe J, Helle F, et al
    IDENTIFICATION OF PIPERAZINYLBENZENESULFONAMIDES AS NEW INHIBITORS OF CLAUDIN-1 TRAFFICKING AND HEPATITIS C VIRUS ENTRY.
    J Virol. 2018 Feb 28. pii: JVI.01982-17. doi: 10.1128/JVI.01982.
    PubMed     Text format     Abstract available


  87. GU J, Hardy J, Boo I, Vietheer P, et al
    Escape of Hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes.
    J Virol. 2018 Feb 21. pii: JVI.02066-17. doi: 10.1128/JVI.02066.
    PubMed     Text format     Abstract available


  88. MOUSTAFA S, Karakasiliotis I, Mavromara P
    Hepatitis C virus core+1/ARFP modulates Cyclin D1/pRb pathway and promotes carcinogenesis.
    J Virol. 2018 Feb 14. pii: JVI.02036-17. doi: 10.1128/JVI.02036.
    PubMed     Text format     Abstract available


  89. COSTAFREDA MI, Kaplan G
    HAVCR1 (CD365) and its mouse ortholog are functional hepatitis A virus (HAV) cellular receptors that mediate HAV infection.
    J Virol. 2018 Feb 7. pii: JVI.02065-17. doi: 10.1128/JVI.02065.
    PubMed     Text format     Abstract available


  90. SHIMIZU Y, Shirasago Y, Kondoh M, Suzuki T, et al
    Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model.
    J Virol. 2018 Feb 7. pii: JVI.02258-17. doi: 10.1128/JVI.02258.
    PubMed     Text format     Abstract available


  91. WIJESUNDARA DK, Gummow J, Li Y, Yu W, et al
    Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.
    J Virol. 2018 Feb 7. pii: JVI.02133-17. doi: 10.1128/JVI.02133.
    PubMed     Text format     Abstract available


  92. TU T, Budzinska MA, Vondran FWR, Shackel NA, et al
    Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via NTCP-dependent uptake of enveloped virus particles.
    J Virol. 2018 Feb 7. pii: JVI.02007-17. doi: 10.1128/JVI.02007.
    PubMed     Text format     Abstract available


  93. SONG M, Sun Y, Tian J, He W, et al
    Silencing Retinoid X Receptor Alpha Expression Enhances Early-stage Hepatitis B Virus Infection In Cell Cultures.
    J Virol. 2018 Feb 7. pii: JVI.01771-17. doi: 10.1128/JVI.01771.
    PubMed     Text format     Abstract available


  94. WONDERLICH ER, Caroline AL, McMillen CM, Walters AW, et al
    Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    January 2018
  95. LI Q, Tong Y, Xu Y, Niu J, et al
    Genetic Analysis of Serum-derived HCV Defective Genomes Revealed Novel Viral Cis-Elements for Virus Replication and Assembly.
    J Virol. 2018 Jan 24. pii: JVI.02182-17. doi: 10.1128/JVI.02182.
    PubMed     Text format     Abstract available


  96. DORING T, Zeyen L, Bartusch C, Prange R, et al
    Hepatitis B Virus Subverts the Autophagy Elongation Complex Atg5-12/16L1 and Does not Require Atg8/LC3 Lipidation for Viral Maturation.
    J Virol. 2018 Jan 24. pii: JVI.01513-17. doi: 10.1128/JVI.01513.
    PubMed     Text format     Abstract available


  97. YI G, Wen Y, Shu C, Han Q, et al
    Correction for Yi et al., "Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses".
    J Virol. 2018;92.
    PubMed     Text format    


  98. DUAN X, Li S, Holmes JA, Tu Z, et al
    MicroRNA-130a regulates both HCV and HBV replication through a central metabolic pathway.
    J Virol. 2018 Jan 10. pii: JVI.02009-17. doi: 10.1128/JVI.02009.
    PubMed     Text format     Abstract available


  99. KANADE GD, Pingale KD, Karpe YA
    Activities of Thrombin and Factor Xa are essential for replication of Hepatitis E virus and are possibly implicated in the ORF1 polyprotein processing.
    J Virol. 2018 Jan 10. pii: JVI.01853-17. doi: 10.1128/JVI.01853.
    PubMed     Text format     Abstract available


  100. KACHKO A, Costafreda MI, Zubkova I, Jacques J, et al
    Determinants in the IgV Domain of human HAVCR1 (TIM-1) are required to enhance Hepatitis C Virus Entry.
    J Virol. 2018 Jan 10. pii: JVI.01742-17. doi: 10.1128/JVI.01742.
    PubMed     Text format     Abstract available


    December 2017
  101. KWEI K, Tang X, Lok AS, Sureau C, et al
    Correction for Kwei et al., "Impaired Virion Secretion by Hepatitis B Virus Immune Escape Mutants and Its Rescue by Wild-Type Envelope Proteins or a Second-Site Mutation".
    J Virol. 2017;91.
    PubMed     Text format    


  102. YANG Z, Wang X, Chi X, Zhao F, et al
    Correction for Yang et al., "Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection".
    J Virol. 2017;91.
    PubMed     Text format    


  103. KIM H, Bose SK, Meyer K, Ray R, et al
    Correction for Kim et al., "Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis".
    J Virol. 2017;91.
    PubMed     Text format    


  104. BEILSTEIN F, Blanchet M, Vaillant A, Sureau C, et al
    Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.
    J Virol. 2017 Dec 6. pii: JVI.01416-17. doi: 10.1128/JVI.01416.
    PubMed     Text format     Abstract available


  105. DIXIT U, Pandey AK, Liu Z, Kumar S, et al
    Correction for Dixit et al., "FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53".
    J Virol. 2017;91.
    PubMed     Text format    


    November 2017
  106. PAUL D, Madan V, Ramirez O, Bencun M, et al
    Glycine-zipper motifs in hepatitis C virus nonstructural protein 4B are required for the establishment of viral replication organelles.
    J Virol. 2017 Nov 22. pii: JVI.01890-17. doi: 10.1128/JVI.01890.
    PubMed     Text format     Abstract available


  107. AGARWAL S, Baccam P, Aggarwal R, Veerapu NS, et al
    Novel Synthesis and Phenotypic Analysis of Mutant Clouds for Hepatitis E Virus Genotype 1.
    J Virol. 2017 Nov 22. pii: JVI.01932-17. doi: 10.1128/JVI.01932.
    PubMed     Text format     Abstract available


  108. SKARDASI G, Chen AY, Michalak TI
    Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.
    J Virol. 2017 Nov 22. pii: JVI.01790-17. doi: 10.1128/JVI.01790.
    PubMed     Text format     Abstract available


  109. SCHWEITZER CJ, Zhang F, Boyer A, Valdez K, et al
    N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
    J Virol. 2017 Nov 8. pii: JVI.01166-17. doi: 10.1128/JVI.01166.
    PubMed     Text format     Abstract available


  110. MORENO-CUBERO E, Subira D, Sanz-de-Villalobos E, Parra-Cid T, et al
    According to HCV infection stage, IL-7 plus 4-1BB triggering alone or combined with PD-1 blockade increases TRAF1low HCV-specific CD8+ cell reactivity.
    J Virol. 2017 Nov 1. pii: JVI.01443-17. doi: 10.1128/JVI.01443.
    PubMed     Text format     Abstract available


  111. BRAHMS A, Mudhasani R, Pinkham C, Kota K, et al
    Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    October 2017
  112. ZHOU T, Ren X, Adams RL, Pyle AM, et al
    NS3 from HCV strain JFH-1 is an unusually robust helicase that is primed to bind and unwind viral RNA.
    J Virol. 2017 Oct 25. pii: JVI.01253-17. doi: 10.1128/JVI.01253.
    PubMed     Text format     Abstract available


  113. STOECK IK, Lee JY, Tabata K, Romero-Brey I, et al
    Hepatitis C virus replication depends on endosomal cholesterol homeostasis.
    J Virol. 2017 Oct 18. pii: JVI.01196-17. doi: 10.1128/JVI.01196.
    PubMed     Text format     Abstract available


  114. CASE JB, Li Y, Elliott R, Lu X, et al
    Murine hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity.
    J Virol. 2017 Oct 18. pii: JVI.01531-17. doi: 10.1128/JVI.01531.
    PubMed     Text format     Abstract available


  115. LI M, Sohn JA, Seeger C
    Distribution of hepatitis B virus nuclear DNA.
    J Virol. 2017 Oct 18. pii: JVI.01391-17. doi: 10.1128/JVI.01391.
    PubMed     Text format     Abstract available


    September 2017
  116. QIN Y, Xue B, Liu C, Wang X, et al
    NLRX1 mediates MAVS degradation to attenuate hepatitis C virus-induced innate immune response through PCBP2.
    J Virol. 2017 Sep 27. pii: JVI.01264-17. doi: 10.1128/JVI.01264.
    PubMed     Text format     Abstract available


  117. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    PubMed     Text format     Abstract available


  118. NAGASHIMA S, Takahashi M, Kobayashi T, Tanggis, et al
    The characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway.
    J Virol. 2017 Sep 6. pii: JVI.00822-17. doi: 10.1128/JVI.00822.
    PubMed     Text format     Abstract available


    August 2017
  119. KAUSHIK N, Subramani C, Anang S, Muthumohan R, et al
    Zinc salts block Hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase.
    J Virol. 2017 Aug 16. pii: JVI.00754-17. doi: 10.1128/JVI.00754.
    PubMed     Text format     Abstract available


  120. LIU N, Zhang J, Yang X, Jiao T, et al
    HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  121. KWON YC, Sasaki R, Meyer K, Ray R, et al
    HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS.
    J Virol. 2017 Aug 9. pii: JVI.01235-17. doi: 10.1128/JVI.01235.
    PubMed     Text format     Abstract available


  122. PIERCE BG, Boucher EN, Piepenbrink KH, Ejemel M, et al
    Structure-Based Design of Hepatitis C Virus Vaccines that Elicit Neutralizing Antibody Responses to a Conserved Epitope.
    J Virol. 2017 Aug 9. pii: JVI.01032-17. doi: 10.1128/JVI.01032.
    PubMed     Text format     Abstract available


  123. SHALABY RE, Iram S, Cakal B, Oropeza CE, et al
    PGC1alpha TRANSCRIPTIONAL ADAPTOR FUNCTION GOVERNS HEPATITIS B VIRUS REPLICATION BY CONTROLLING HBcAg/p21 PROTEIN MEDIATED CAPSID FORMATION.
    J Virol. 2017 Aug 2. pii: JVI.00790-17. doi: 10.1128/JVI.00790.
    PubMed     Text format     Abstract available


  124. ZHONG L, Shu W, Dai W, Gao B, et al
    Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    July 2017
  125. KIM JY, Wang L, Lee J, Ou JJ, et al
    HCV induces the localization of lipid rafts to autophagosomes for its RNA replication.
    J Virol. 2017 Jul 26. pii: JVI.00541-17. doi: 10.1128/JVI.00541.
    PubMed     Text format     Abstract available


  126. SOORYANARAIN H, Rogers AJ, Cao D, Haac MER, et al
    ISG15 modulates type-I interferon signaling and antiviral response during hepatitis E virus replication.
    J Virol. 2017 Jul 19. pii: JVI.00621-17. doi: 10.1128/JVI.00621.
    PubMed     Text format     Abstract available


  127. YIN P, Li Y, Zhang L
    Sec24C-Dependent Transport of Claudin-1 Regulates Hepatitis C Virus Entry.
    J Virol. 2017 Jul 5. pii: JVI.00629-17. doi: 10.1128/JVI.00629.
    PubMed     Text format     Abstract available


    June 2017
  128. WELLER R, Hueging K, Brown RJP, Todt D, et al
    Hepatitis C virus strain-dependent usage of apolipoprotein E modulates assembly efficiency and specific infectivity of secreted virions.
    J Virol. 2017 Jun 28. pii: JVI.00422-17. doi: 10.1128/JVI.00422.
    PubMed     Text format     Abstract available


  129. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Entry and release of hepatitis C virus in polarized human hepatocytes.
    J Virol. 2017 Jun 28. pii: JVI.00478-17. doi: 10.1128/JVI.00478.
    PubMed     Text format     Abstract available


  130. CEVIK RE, Cesarec M, Da Silva Filipe A, Licastro D, et al
    Hepatitis C virus NS5A targets the nucleosome assembly protein NAP1L1 to control the innate cellular response.
    J Virol. 2017 Jun 28. pii: JVI.00880-17. doi: 10.1128/JVI.00880.
    PubMed     Text format     Abstract available


  131. LUO J, Cui X, Gao L, Hu J, et al
    Identification of Intermediate in Hepatitis B Virus CCC DNA Formation and Sensitive and Selective CCC DNA Detection.
    J Virol. 2017 Jun 21. pii: JVI.00539-17. doi: 10.1128/JVI.00539.
    PubMed     Text format     Abstract available


  132. GOONAWARDANE N, Gebhardt A, Bartlett C, Pichlmair A, et al
    Phosphorylation of serine 225 in hepatitis C virus NS5A regulates protein-protein interactions.
    J Virol. 2017 Jun 14. pii: JVI.00805-17. doi: 10.1128/JVI.00805.
    PubMed     Text format     Abstract available


    May 2017
  133. WONG MT, Chen SS
    Hepatitis C Virus Subverts Human Choline Kinase-alpha to Bridge PI4KIIIalpha and NS5A and Upregulates PI4KIIIalpha Activation, Thereby Promoting the Translocation of the Ternary Complex to the ER for Viral Replication.
    J Virol. 2017 May 31. pii: JVI.00355-17. doi: 10.1128/JVI.00355.
    PubMed     Text format     Abstract available


  134. WU S, Zhao Q, Zhang P, Kulp J, et al
    Discovery and mechanistic study of benzamide derivatives that modulate hepatitis B virus capsid assembly.
    J Virol. 2017 May 31. pii: JVI.00519-17. doi: 10.1128/JVI.00519.
    PubMed     Text format     Abstract available


  135. LI Z, Li Y, Bi Y, Zhang H, et al
    Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
    J Virol. 2017 May 24. pii: JVI.02227-16. doi: 10.1128/JVI.02227.
    PubMed     Text format     Abstract available


  136. SYED GH, Khan M, Yang S, Siddiqui A, et al
    Hepatitis C virus lipoviroparticles (HCV-LVP) assemble in the endoplasmic reticulum (ER) and bud off from the ER to Golgi in COPII vesicles.
    J Virol. 2017 May 17. pii: JVI.00499-17. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available


  137. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Correction for Devhare et al., "Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells".
    J Virol. 2017;91.
    PubMed     Text format    


    April 2017
  138. FILSKOV J, Mikkelsen M, Hansen PR, Christensen JP, et al
    Broadening CD4+ and CD8+ T cell responses against hepatitis C virus by vaccination with NS3 overlapping peptide panels in cross-priming liposomes.
    J Virol. 2017 Apr 26. pii: JVI.00130-17. doi: 10.1128/JVI.00130.
    PubMed     Text format     Abstract available


  139. HSU SC, Lo CW, Pan TC, Lee KY, et al
    Serine 235 Is the Primary NS5A Hyper-Phosphorylation Site Responsible for HCV Replication.
    J Virol. 2017 Apr 26. pii: JVI.00194-17. doi: 10.1128/JVI.00194.
    PubMed     Text format     Abstract available


  140. FAN H, Qiao L, Kang KD, Fan J, et al
    Attachment and Post-Attachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
    J Virol. 2017 Apr 12. pii: JVI.00280-17. doi: 10.1128/JVI.00280.
    PubMed     Text format     Abstract available


    January 2017
  141. WALTER S, Rasche A, Moreira-Soto A, Pfaender S, et al
    Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available


    October 2016
  142. LOGAN M, Law J, Wong JA, Hockman D, et al
    Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG.
    J Virol. 2016 Oct 19. pii: JVI.01552.
    PubMed     Text format     Abstract available


    July 2016
  143. DI SCALA M, Otano I, Gil-Farina I, Vanrell L, et al
    Complementary effects of IL-15 and IFN-alpha induce immunity in HBV transgenic mice.
    J Virol. 2016 Jul 20. pii: JVI.01030.
    PubMed     Text format     Abstract available


    June 2016
  144. MACPARLAND SA, Ma XZ, Chen L, Khattar R, et al
    Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    J Virol. 2016;90:5549-60.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: